Article
Patrick Gleason, PharmD, Talks About Benefit Design Trends in Specialty Pharmacy
Patrick Gleason, PharmD, Director of Health Outcomes, Prime Therapeutics, says benefit design trends in specialty pharmacy show that the preferred specialty tier is generally a cost share of around one hundred dollars for a 30-day supply.
Patrick Gleason, PharmD, Director of Health Outcomes, Prime Therapeutics, says benefit design trends in specialty pharmacy show that the preferred specialty tier is generally a cost share of around one hundred dollars for a 30-day supply. When cost shares rise above one hundred dollars, they find a decrease in utilization, especially in the choice to initiate or continue therapy of adherent and persistent medications.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
